Celio, Luigi
Cortinovis, Diego
Cogoni, Alessio Aligi
Cavanna, Luigi
Martelli, Olga
Carnio, Simona
Collovà, Elena
Bertolini, Federica
Petrelli, Fausto
Cassano, Alessandra
Chiari, Rita
Zanelli, Francesca
Pisconti, Salvatore
Vittimberga, Isabella
Letizia, Antonietta
Misino, Andrea
Gernone, Angela
Bonizzoni, Erminio
Pilotto, Sara
De Placido, Sabino
Bria, Emilio
Clinical trials referenced in this document:
Documents that mention this clinical trial
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study)
https://doi.org/10.1038/s41598-023-28464-9
Article History
Received: 10 October 2022
Accepted: 18 January 2023
First Online: 23 January 2023
Competing interests
: Luigi Celio has received consulting fees from Italfarmaco SpA, and Kyowa Kirin; speaker’s fee from Berlin-Chemie AG, and Helsinn. Diego Cortinovis has received speaker’s bureau and scientific advisor fees from Roche, AstraZeneca, BMS, MSD, Boehringer, Amgen, Novartis, and Lilly. Federica Bertolini has received speaker’s fee from MSD, AstraZeneca, and BMS; advisory board fees from MSD, Eli-Lilly, and Sanofi. Rita Chiari has declared speaker's fee - advisory boards from Astrazeneca, Roche, BMS, MSD, Pfizer, and Takeda. Erminio Bonizzoni received consulting fees from Helsinn. Sara Pilotto has received fees for consulting, advisory role and lectures from AstraZeneca, BMS, Boehringer, Eli-Lilly, Merck, Novartis, Roche, Amgen, Takeda. Emilio Bria received speakers’ and travels’ fees from MSD, AstraZeneca, Celgene, Pfizer, Helsinn, Eli-Lilly, BMS, Novartis and Roche, as well as institutional research grants from AstraZeneca and Roche. All remaining authors have declared no conflicts of interest.